Open AccessEffect of sustained-release long-acting intravitreal dexamethasone implant in patients of non-proliferative diabetic retinopathy undergoing phacoemulsification: A randomized controlled trial
Author(s) -
Jagat Ram,
ParulChawla Gupta,
Mahendra Kumar,
Aniruddha Agarwal,
Vishali Gupta,
Ramandeep Singh,
Reema Bansal,
Deeksha Katoch,
Mohit Dogra,
Amod Gupta
Publication year - 2021
Publication title -
indian journal of ophthalmology/indian journal of ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.542
H-Index - 51
eISSN - 1998-3689
pISSN - 0301-4738
DOI - 10.4103/ijo.ijo_749_21
Subject(s) - medicine , phacoemulsification , diabetic retinopathy , dexamethasone , macular edema , ophthalmology , diabetes mellitus , randomized controlled trial , visual acuity , intraocular pressure , cataract surgery , surgery , endocrinology
Cataract and diabetes, both being a major health care problem, an intervention evaluated for the combination of the two attains paramount importance. The purpose of the study was to determine the role of intraoperative intravitreal dexamethasone implant in patients with diabetic retinopathy with/without macula edema undergoing phacoemulsification.